You just read:

OncoSec Announces Collaborative Research Agreement in HER2+ Breast Cancer Evaluating the Use of TAVO™ in Combination with Plasmid DNA Vaccines with a World Leading Academic Medical Center

News provided by

OncoSec Medical Incorporated

Apr 17, 2019, 08:00 ET